Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Randomized Study of the Tolerability and Safety of the OsciPulse Device for the Prevention of VTE

NCT04625673 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04625673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Randomized Study of the Tolerability and Safety of the OsciPulse Device for the Prevention of VTE
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
May 12, 2021
Completion date
October 15, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary thromboembolisms, venous thromboembolism